IBDEI10X ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16646,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16646,1,3,0)
;;=3^Malig Neop Right Male Breast,Unspec Site
;;^UTILITY(U,$J,358.3,16646,1,4,0)
;;=4^C50.921
;;^UTILITY(U,$J,358.3,16646,2)
;;=^5001198
;;^UTILITY(U,$J,358.3,16647,0)
;;=C90.02^^61^775^176
;;^UTILITY(U,$J,358.3,16647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16647,1,3,0)
;;=3^Multiple Myeloma,In Relapse
;;^UTILITY(U,$J,358.3,16647,1,4,0)
;;=4^C90.02
;;^UTILITY(U,$J,358.3,16647,2)
;;=^5001753
;;^UTILITY(U,$J,358.3,16648,0)
;;=D51.9^^61^775^25
;;^UTILITY(U,$J,358.3,16648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16648,1,3,0)
;;=3^Anemia in Vitamin B12 Deficiency
;;^UTILITY(U,$J,358.3,16648,1,4,0)
;;=4^D51.9
;;^UTILITY(U,$J,358.3,16648,2)
;;=^5002289
;;^UTILITY(U,$J,358.3,16649,0)
;;=C79.51^^61^775^35
;;^UTILITY(U,$J,358.3,16649,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16649,1,3,0)
;;=3^Bone Mets
;;^UTILITY(U,$J,358.3,16649,1,4,0)
;;=4^C79.51
;;^UTILITY(U,$J,358.3,16649,2)
;;=^5001350
;;^UTILITY(U,$J,358.3,16650,0)
;;=C80.1^^61^775^171
;;^UTILITY(U,$J,358.3,16650,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16650,1,3,0)
;;=3^Malig Neop,Primary,Unspec Site
;;^UTILITY(U,$J,358.3,16650,1,4,0)
;;=4^C80.1
;;^UTILITY(U,$J,358.3,16650,2)
;;=^5001389
;;^UTILITY(U,$J,358.3,16651,0)
;;=C80.0^^61^775^172
;;^UTILITY(U,$J,358.3,16651,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16651,1,3,0)
;;=3^Malig Neop,Unspec Primary or Secondary
;;^UTILITY(U,$J,358.3,16651,1,4,0)
;;=4^C80.0
;;^UTILITY(U,$J,358.3,16651,2)
;;=^5001388
;;^UTILITY(U,$J,358.3,16652,0)
;;=E28.39^^61^775^96
;;^UTILITY(U,$J,358.3,16652,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16652,1,3,0)
;;=3^Hypogonadism,Ovarian
;;^UTILITY(U,$J,358.3,16652,1,4,0)
;;=4^E28.39
;;^UTILITY(U,$J,358.3,16652,2)
;;=^5002752
;;^UTILITY(U,$J,358.3,16653,0)
;;=E29.1^^61^775^97
;;^UTILITY(U,$J,358.3,16653,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16653,1,3,0)
;;=3^Hypogonadism,Testicular
;;^UTILITY(U,$J,358.3,16653,1,4,0)
;;=4^E29.1
;;^UTILITY(U,$J,358.3,16653,2)
;;=^5002754
;;^UTILITY(U,$J,358.3,16654,0)
;;=C96.20^^61^775^111
;;^UTILITY(U,$J,358.3,16654,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16654,1,3,0)
;;=3^Malig Mast Cell Neoplasm,Unspec
;;^UTILITY(U,$J,358.3,16654,1,4,0)
;;=4^C96.20
;;^UTILITY(U,$J,358.3,16654,2)
;;=^5151293
;;^UTILITY(U,$J,358.3,16655,0)
;;=C96.22^^61^775^173
;;^UTILITY(U,$J,358.3,16655,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16655,1,3,0)
;;=3^Mast Cell Sarcoma
;;^UTILITY(U,$J,358.3,16655,1,4,0)
;;=4^C96.22
;;^UTILITY(U,$J,358.3,16655,2)
;;=^5151295
;;^UTILITY(U,$J,358.3,16656,0)
;;=D64.9^^61^775^26
;;^UTILITY(U,$J,358.3,16656,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16656,1,3,0)
;;=3^Anemia,Unspec
;;^UTILITY(U,$J,358.3,16656,1,4,0)
;;=4^D64.9
;;^UTILITY(U,$J,358.3,16656,2)
;;=^5002351
;;^UTILITY(U,$J,358.3,16657,0)
;;=D59.10^^61^775^32
;;^UTILITY(U,$J,358.3,16657,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16657,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,16657,1,4,0)
;;=4^D59.10
;;^UTILITY(U,$J,358.3,16657,2)
;;=^5159101
;;^UTILITY(U,$J,358.3,16658,0)
;;=D59.11^^61^775^33
;;^UTILITY(U,$J,358.3,16658,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16658,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Warm
;;^UTILITY(U,$J,358.3,16658,1,4,0)
;;=4^D59.11
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10X 3784 printed Oct 16, 2024@18:00:25 Page 2
IBDEI10X ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16646,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,16646,1,3,0)
+4 ;;=3^Malig Neop Right Male Breast,Unspec Site
+5 ;;^UTILITY(U,$J,358.3,16646,1,4,0)
+6 ;;=4^C50.921
+7 ;;^UTILITY(U,$J,358.3,16646,2)
+8 ;;=^5001198
+9 ;;^UTILITY(U,$J,358.3,16647,0)
+10 ;;=C90.02^^61^775^176
+11 ;;^UTILITY(U,$J,358.3,16647,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,16647,1,3,0)
+14 ;;=3^Multiple Myeloma,In Relapse
+15 ;;^UTILITY(U,$J,358.3,16647,1,4,0)
+16 ;;=4^C90.02
+17 ;;^UTILITY(U,$J,358.3,16647,2)
+18 ;;=^5001753
+19 ;;^UTILITY(U,$J,358.3,16648,0)
+20 ;;=D51.9^^61^775^25
+21 ;;^UTILITY(U,$J,358.3,16648,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,16648,1,3,0)
+24 ;;=3^Anemia in Vitamin B12 Deficiency
+25 ;;^UTILITY(U,$J,358.3,16648,1,4,0)
+26 ;;=4^D51.9
+27 ;;^UTILITY(U,$J,358.3,16648,2)
+28 ;;=^5002289
+29 ;;^UTILITY(U,$J,358.3,16649,0)
+30 ;;=C79.51^^61^775^35
+31 ;;^UTILITY(U,$J,358.3,16649,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,16649,1,3,0)
+34 ;;=3^Bone Mets
+35 ;;^UTILITY(U,$J,358.3,16649,1,4,0)
+36 ;;=4^C79.51
+37 ;;^UTILITY(U,$J,358.3,16649,2)
+38 ;;=^5001350
+39 ;;^UTILITY(U,$J,358.3,16650,0)
+40 ;;=C80.1^^61^775^171
+41 ;;^UTILITY(U,$J,358.3,16650,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,16650,1,3,0)
+44 ;;=3^Malig Neop,Primary,Unspec Site
+45 ;;^UTILITY(U,$J,358.3,16650,1,4,0)
+46 ;;=4^C80.1
+47 ;;^UTILITY(U,$J,358.3,16650,2)
+48 ;;=^5001389
+49 ;;^UTILITY(U,$J,358.3,16651,0)
+50 ;;=C80.0^^61^775^172
+51 ;;^UTILITY(U,$J,358.3,16651,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,16651,1,3,0)
+54 ;;=3^Malig Neop,Unspec Primary or Secondary
+55 ;;^UTILITY(U,$J,358.3,16651,1,4,0)
+56 ;;=4^C80.0
+57 ;;^UTILITY(U,$J,358.3,16651,2)
+58 ;;=^5001388
+59 ;;^UTILITY(U,$J,358.3,16652,0)
+60 ;;=E28.39^^61^775^96
+61 ;;^UTILITY(U,$J,358.3,16652,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,16652,1,3,0)
+64 ;;=3^Hypogonadism,Ovarian
+65 ;;^UTILITY(U,$J,358.3,16652,1,4,0)
+66 ;;=4^E28.39
+67 ;;^UTILITY(U,$J,358.3,16652,2)
+68 ;;=^5002752
+69 ;;^UTILITY(U,$J,358.3,16653,0)
+70 ;;=E29.1^^61^775^97
+71 ;;^UTILITY(U,$J,358.3,16653,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,16653,1,3,0)
+74 ;;=3^Hypogonadism,Testicular
+75 ;;^UTILITY(U,$J,358.3,16653,1,4,0)
+76 ;;=4^E29.1
+77 ;;^UTILITY(U,$J,358.3,16653,2)
+78 ;;=^5002754
+79 ;;^UTILITY(U,$J,358.3,16654,0)
+80 ;;=C96.20^^61^775^111
+81 ;;^UTILITY(U,$J,358.3,16654,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,16654,1,3,0)
+84 ;;=3^Malig Mast Cell Neoplasm,Unspec
+85 ;;^UTILITY(U,$J,358.3,16654,1,4,0)
+86 ;;=4^C96.20
+87 ;;^UTILITY(U,$J,358.3,16654,2)
+88 ;;=^5151293
+89 ;;^UTILITY(U,$J,358.3,16655,0)
+90 ;;=C96.22^^61^775^173
+91 ;;^UTILITY(U,$J,358.3,16655,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,16655,1,3,0)
+94 ;;=3^Mast Cell Sarcoma
+95 ;;^UTILITY(U,$J,358.3,16655,1,4,0)
+96 ;;=4^C96.22
+97 ;;^UTILITY(U,$J,358.3,16655,2)
+98 ;;=^5151295
+99 ;;^UTILITY(U,$J,358.3,16656,0)
+100 ;;=D64.9^^61^775^26
+101 ;;^UTILITY(U,$J,358.3,16656,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,16656,1,3,0)
+104 ;;=3^Anemia,Unspec
+105 ;;^UTILITY(U,$J,358.3,16656,1,4,0)
+106 ;;=4^D64.9
+107 ;;^UTILITY(U,$J,358.3,16656,2)
+108 ;;=^5002351
+109 ;;^UTILITY(U,$J,358.3,16657,0)
+110 ;;=D59.10^^61^775^32
+111 ;;^UTILITY(U,$J,358.3,16657,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,16657,1,3,0)
+114 ;;=3^Autoimmune Hemolytic Anemia,Unspec
+115 ;;^UTILITY(U,$J,358.3,16657,1,4,0)
+116 ;;=4^D59.10
+117 ;;^UTILITY(U,$J,358.3,16657,2)
+118 ;;=^5159101
+119 ;;^UTILITY(U,$J,358.3,16658,0)
+120 ;;=D59.11^^61^775^33
+121 ;;^UTILITY(U,$J,358.3,16658,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,16658,1,3,0)
+124 ;;=3^Autoimmune Hemolytic Anemia,Warm
+125 ;;^UTILITY(U,$J,358.3,16658,1,4,0)
+126 ;;=4^D59.11
